The impact of gadolinium‐based MR contrast on radiotherapy planning for oropharyngeal treatment on the MR Linac

Volume: 49, Issue: 1, Pages: 510 - 520
Published: Nov 22, 2021
Abstract
Gadolinium-based contrast agents (GBCAs) may add value to magnetic resonance (MR)-only radiotherapy (RT) workflows including on hybrid machines such as the MR Linac. The impact of GBCAs on RT dose distributions however have not been well studied. This work used retrospective GBCA-enhanced datasets to assess the dosimetric effect of GBCAs on head and neck plans.Ten patients with oropharyngeal squamous cell carcinoma receiving RT from November...
Paper Details
Title
The impact of gadolinium‐based MR contrast on radiotherapy planning for oropharyngeal treatment on the MR Linac
Published Date
Nov 22, 2021
Volume
49
Issue
1
Pages
510 - 520
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.